Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GBT440 MRI cerebral perfusion and oxygenation substudy in sickle cell disease
NL-OMON46527Withdrawn
- Sponsor
- Amsterdam University Medical Center
- Start
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Single-arm trial of voxelotor in sickle cell disease (SCD), sponsored by Amsterdam University Medical Center. Primary endpoints: Cerebral blood flow, Cerebrovascular reserve and 5 more. Planned start May 2018; status: withdrawn.
02
Drugs
voxelotor
03
Conditions
sickle cell disease (SCD)
Beyond the preview
Go deeper on NL-OMON46527.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON46527.